Last reviewed · How we verify
Experimental Drug SESC 01 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Experimental Drug SESC 01 (Experimental Drug SESC 01) — South End Skin Care.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Experimental Drug SESC 01 TARGET | Experimental Drug SESC 01 | South End Skin Care | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Experimental Drug SESC 01 CI watch — RSS
- Experimental Drug SESC 01 CI watch — Atom
- Experimental Drug SESC 01 CI watch — JSON
- Experimental Drug SESC 01 alone — RSS
Cite this brief
Drug Landscape (2026). Experimental Drug SESC 01 — Competitive Intelligence Brief. https://druglandscape.com/ci/experimental-drug-sesc-01. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab